OBI Pharma Cash Flow-to-Debt Ratio
OBI Pharma cash flow-to-debt ratio. OBI Pharma (4174) has a Cash Flow-to-Debt Ratio of -0.59x as of June 2026, meaning its operating cash flow of NT$-290.40 Million could theoretically repay -1% of its total liabilities (NT$495.56 Million) in one year. Check 4174 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of OBI Pharma (2011–2025)
Cash flow-to-debt ratio of OBI Pharma from 2011 to 2025. Historical debt coverage capacity for OBI Pharma across 15 annual periods. Check cash flow reinvestment rate of OBI Pharma to assess the company's total reinvestment commitment from operating cash flow.
OBI Pharma Cash Flow-to-Debt Ratio by Year (2011–2025)
OBI Pharma cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for OBI Pharma. For the full cash flow conversion analysis, see OBI Pharma (4174) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.90x | NT$-2.02 Billion | NT$696.13 Million | ▼ -31.9% |
| 2024 | -2.20x | NT$-1.83 Billion | NT$833.38 Million | ▲ +13.4% |
| 2023 | -2.54x | NT$-1.65 Billion | NT$650.45 Million | ▲ +21.9% |
| 2022 | -3.26x | NT$-1.62 Billion | NT$497.57 Million | ▼ -88.4% |
| 2021 | -1.73x | NT$-1.06 Billion | NT$615.95 Million | ▲ +46.1% |
| 2020 | -3.21x | NT$-1.61 Billion | NT$502.09 Million | ▼ -40.6% |
| 2019 | -2.28x | NT$-1.05 Billion | NT$459.14 Million | ▲ +37.7% |
| 2018 | -3.66x | NT$-864.31 Million | NT$236.03 Million | ▲ +57.1% |
| 2017 | -8.54x | NT$-1.11 Billion | NT$129.66 Million | ▼ -70.0% |
| 2016 | -5.02x | NT$-840.10 Million | NT$167.32 Million | ▼ -71.3% |
| 2015 | -2.93x | NT$-372.20 Million | NT$127.00 Million | ▲ +72.1% |
| 2014 | -10.49x | NT$-464.22 Million | NT$44.24 Million | ▼ -317.7% |
| 2013 | -2.51x | NT$-104.16 Million | NT$41.46 Million | ▲ +5.2% |
| 2012 | -2.65x | NT$-117.64 Million | NT$44.40 Million | ▲ +92.6% |
| 2011 | -35.61x | NT$-508.22 Million | NT$14.27 Million | — |